婷婷丁香久久,日日夜夜天天久久,中文av岛国无码免费播放,国产最新进精品视频,一进一出下面喷白浆视频,天天夜夜人人,97免费在线观看视频

China's FDA approves new drug for treating HIV

Source: Xinhua| 2018-06-07 22:51:24|Editor: yan
Video PlayerClose

NANJING, June 7 (Xinhua) -- China Food and Drug Administration (FDA) has approved the sale of a new drug for the treatment of HIV-1 infection, the maker of the drug said.

Aikening, or albuvirtide for injection (ABT), can be used with other antiretroviral drugs to treat infected patients who have been treated with antiviral drugs but still suffer from viral replication, according to Frontier Biotech, a pharmaceutical company based in the east Chinese city of Nanjing.

Data from clinical trials showed that Aikening was effective against major strains of HIV, including resistant viruses, and the efficacy was long-acting, according to the company.

"As a long-acting injectable drug with a new mechanism of action, ABT has the potential to be a significant addition and improvement to the currently all oral drug regimen," said Xie Dong, chairman of Frontier Biotech.

Patients who used Aikening didn't show severe symptoms of side-effects, and they only have to take one injection every week, according to the company.

"It is expected that Aikening will have a big potential in markets at home and abroad," said Li Taisheng, an AIDS expert with Peking Union Medical College Hospital.

Official data showed that as of June last year, China had about 718,270 people living with HIV/AIDS and 221,628 people had died of AIDS-related diseases.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011105521372379911